3 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
| Phase 1 | 1 | Withdrawn 1 |
Follow PATH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults Shigella flexneri 2a whole cell (Sf2aWC) vaccine and double mutant E. coli heat labile toxin (dmLT), Shigella flexneri 2a whole cell (Sf2aWC) vaccine, Placebo - Shigella Sonnei Dysenteries | Phase 2 | Withdrawn | PATH | 2017-08-01 | 2017-11-20 | |
| Efficacy of iOWH032 in Dehydrating Cholera iOWH032 - Secretory Diarrhea | Phase 2 | Withdrawn | PATH | 2014-06-01 | 2014-09-26 | |
| Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV], Placebo - Rotavirus Infections | Phase 1 / Phase 2 | Withdrawn | Shantha Biotechnics Limited | 240 | 2009-09-01 | 2010-02-03 |
Cholera (1) · Diarrhea (1) · Dysentery (1) · Dysentery, Bacillary (1) · Rotavirus Infections (1)
Bangladesh (1) · India (1) · United States (1)
Raman Rao, MD (1) · Wasif A Khan, MBBS/MHS (1) · Wilbur Chen, MD, MS (1)